Jianbing Liu

Taiyuan, 030001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Author's Reply: Letter to the Editor: Concerns Regarding Folic Acid in the Prevention and Treatment of Cervical Cancer.

Author's Reply: Letter to the Editor: Concerns Regarding Folic Acid in the Prevention and Treatment of Cervical Cancer.

Journal: Nutrition reviews

Published: June 01, 2026

Association Between Folate Status and Risk of Cervical Cancer: A Systematic Review, Dose-Response Meta-analysis, and Mendelian Randomization Study.

Association Between Folate Status and Risk of Cervical Cancer: A Systematic Review, Dose-Response Meta-analysis, and Mendelian Randomization Study.

Journal: Nutrition reviews

Published: March 11, 2026

Trifluoperazine induces ferroptosis in acute myeloid leukemia by suppressing the Nrf2/SLC7A11/GPX4 axis.

Trifluoperazine induces ferroptosis in acute myeloid leukemia by suppressing the Nrf2/SLC7A11/GPX4 axis.

Journal: European journal of pharmacology

Published: February 24, 2026

miR-141-5p positively regulates ACVRL1 expression to promote cervical cancer progression.

miR-141-5p positively regulates ACVRL1 expression to promote cervical cancer progression.

Journal: Human cell

Published: January 10, 2026

Correction: Proteomics analysis reveals FEN1 as a promising therapeutic target against small cell neuroendocrine carcinoma of the cervix.

Correction: Proteomics analysis reveals FEN1 as a promising therapeutic target against small cell neuroendocrine carcinoma of the cervix.

Journal: Scientific reports

Published: October 07, 2025

Correction: IL-32/NFκB/miR-205 loop sustains the high expression of IL-32 and enhances the motility of cervical cancer cells.

Correction: IL-32/NFκB/miR-205 loop sustains the high expression of IL-32 and enhances the motility of cervical cancer cells.

Journal: Human cell

Published: July 22, 2025

Proteomics analysis reveals FEN1 as a promising therapeutic target against small cell neuroendocrine carcinoma of the cervix.

Proteomics analysis reveals FEN1 as a promising therapeutic target against small cell neuroendocrine carcinoma of the cervix.

Journal: Scientific reports

Published: May 10, 2025

Tubeimoside I induces mitophagy by activating the PINK1/Parkin/Mfn2 signaling pathway in acute myeloid leukemia cells.

Tubeimoside I induces mitophagy by activating the PINK1/Parkin/Mfn2 signaling pathway in acute myeloid leukemia cells.

Journal: Translational oncology

Published: September 05, 2024

Overexpression of RBM4 promotes acute myeloid leukemia cell differentiation by regulating alternative splicing of TFEB.

Overexpression of RBM4 promotes acute myeloid leukemia cell differentiation by regulating alternative splicing of TFEB.

Journal: The Journal of biological chemistry

Published: March 11, 2024

IL-32 regulates trophoblast invasion through miR-205-NFκB-MMP2/9 axis contributing to the pregnancy-induced hypertension†.

IL-32 regulates trophoblast invasion through miR-205-NFκB-MMP2/9 axis contributing to the pregnancy-induced hypertension†.

Journal: Biology of reproduction

Published: February 25, 2024

Inhibition of ITGA2 suppresses cervical tumorigenesis and metastasis by targeting the AKT/mTOR signaling pathway.

Inhibition of ITGA2 suppresses cervical tumorigenesis and metastasis by targeting the AKT/mTOR signaling pathway.

Journal: Genes & diseases

Published: September 05, 2023

IL-32/NFκB/miR-205 loop sustains the high expression of IL-32 and enhances the motility of cervical cancer cells.

IL-32/NFκB/miR-205 loop sustains the high expression of IL-32 and enhances the motility of cervical cancer cells.

Journal: Human cell

Published: August 25, 2023

Showing 1-12 of 17

Last Updated: 09/26/2026